Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Hancock

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Aging Clinical and Experimental Research|March 10, 2022
The pupil constriction to light is associated with cognitive measures in middle-aged and older adultsYanjun Chen, Scott Hetzel, Alex A Pinto, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 30, 2024
Midlife sensory and motor functions improve long-term predictions of cognitive decline and incidence of cognitive impairmentCarla R Schubert, A Alex Pinto, Adam J Paulsen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 13, 2024
Midlife sensory and motor functions improve prediction of blood-based measures of neurodegeneration and Alzheimer's disease in late middle-ageAdam J Paulsen, A Alex Pinto, Carla R Schubert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2026
Midlife sensory and motor measures among best predictors in parsimonious models of long-term cognitive decline and incidence of cognitive impairment in aging adultsNatascha Merten, A Alex Pinto, Carla R Schubert, et al.
Neurobiology of Aging|October 9, 2022
Associations of sensory and motor function with blood-based biomarkers of neurodegeneration and Alzheimer's disease in midlifeAdam J Paulsen, Carla R Schubert, Alex A Pinto, et al.
Journal of Alzheimer'S Disease : JAD|April 21, 2020
Association of Cardiovascular Risk Factors with Cerebral Perfusion in Whites and African AmericansLindsay R Clark, Megan Zuelsdorff, Derek Norton, et al.
Advances in Therapy|June 11, 2024
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel FumarateMark Gudesblatt, Barbara Bumstead, Marijean Buhse, et al.
Multiple Sclerosis and Related Disorders|November 18, 2022
Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and cliniciansDaija A Jackson, Rachel Nicholson, Catherine Bergmann, et al.
Multiple Sclerosis and Related Disorders|March 25, 2023
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?Hans Bogaardt, Daniel Golan, Marissa A Barrera, et al.
Journal of Neurology|December 13, 2023
Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosisThomas J Covey, Daniel Golan, Robert Sergott, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Aging Clinical and Experimental Research|March 10, 2022
The pupil constriction to light is associated with cognitive measures in middle-aged and older adultsYanjun Chen, Scott Hetzel, Alex A Pinto, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 30, 2024
Midlife sensory and motor functions improve long-term predictions of cognitive decline and incidence of cognitive impairmentCarla R Schubert, A Alex Pinto, Adam J Paulsen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 13, 2024
Midlife sensory and motor functions improve prediction of blood-based measures of neurodegeneration and Alzheimer's disease in late middle-ageAdam J Paulsen, A Alex Pinto, Carla R Schubert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2026
Midlife sensory and motor measures among best predictors in parsimonious models of long-term cognitive decline and incidence of cognitive impairment in aging adultsNatascha Merten, A Alex Pinto, Carla R Schubert, et al.
Neurobiology of Aging|October 9, 2022
Associations of sensory and motor function with blood-based biomarkers of neurodegeneration and Alzheimer's disease in midlifeAdam J Paulsen, Carla R Schubert, Alex A Pinto, et al.
Journal of Alzheimer'S Disease : JAD|April 21, 2020
Association of Cardiovascular Risk Factors with Cerebral Perfusion in Whites and African AmericansLindsay R Clark, Megan Zuelsdorff, Derek Norton, et al.
Advances in Therapy|June 11, 2024
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel FumarateMark Gudesblatt, Barbara Bumstead, Marijean Buhse, et al.
Multiple Sclerosis and Related Disorders|November 18, 2022
Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and cliniciansDaija A Jackson, Rachel Nicholson, Catherine Bergmann, et al.
Multiple Sclerosis and Related Disorders|March 25, 2023
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?Hans Bogaardt, Daniel Golan, Marissa A Barrera, et al.
Journal of Neurology|December 13, 2023
Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosisThomas J Covey, Daniel Golan, Robert Sergott, et al.
Pageof 4